Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain... Show more
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MYHA | 24.94 | 0.01 | +0.06% |
| State Street®My2027 HighYield CrptBdETF | |||
| EQAL | 59.30 | -0.09 | -0.15% |
| Invesco Russell 1000 Equal Weight ETF | |||
| SCHF | 27.43 | -0.16 | -0.58% |
| Schwab International Equity ETF™ | |||
| HDLB | 17.67 | -0.11 | -0.60% |
| ETRACS Mny Py 2xLgd US Hg Dv Lw Vl ETN B | |||
| MPA | 10.90 | -0.07 | -0.64% |
| Blackrock Muniyield Pennsylvania Quality Fund | |||
A.I.dvisor tells us that HNGE and TEM have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNGE and TEM's prices will move in lockstep.
| Ticker / NAME | Correlation To HNGE | 1D Price Change % | ||
|---|---|---|---|---|
| HNGE | 100% | -0.53% | ||
| TEM - HNGE | 32% Poorly correlated | -0.95% | ||
| TDOC - HNGE | 31% Poorly correlated | +1.98% | ||
| WEAV - HNGE | 29% Poorly correlated | -0.30% | ||
| VEEV - HNGE | 28% Poorly correlated | +1.10% | ||
| HCAT - HNGE | 28% Poorly correlated | +0.48% | ||
More | ||||
| Ticker / NAME | Correlation To HNGE | 1D Price Change % |
|---|---|---|
| HNGE | 100% | -0.53% |
| Services to the Health Industry industry (45 stocks) | 25% Poorly correlated | +0.91% |
| Health Services industry (245 stocks) | 15% Poorly correlated | -0.79% |
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HNGE advanced for three days, in of 74 cases, the price rose further within the following month. The odds of a continued upward trend are .
HNGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 32 cases where HNGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for HNGE moved out of overbought territory on July 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 6 similar instances where the indicator moved out of overbought territory. In of the 6 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HNGE as a result. In of 22 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HNGE turned negative on July 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HNGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HNGE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HNGE's P/B Ratio (51.813) is very high in comparison to the industry average of (7.980). P/E Ratio (32.000) is within average values for comparable stocks, (48.282). HNGE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.554). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (8.937) is also within normal values, averaging (5.788).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HNGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.